Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2018 Dec;29(8):877-880.
doi: 10.1111/pai.12977. Epub 2018 Nov 13.

Circulating 25-hydroxyvitamin D, nasopharyngeal microbiota, and bronchiolitis severity

Affiliations
Multicenter Study

Circulating 25-hydroxyvitamin D, nasopharyngeal microbiota, and bronchiolitis severity

Laura Toivonen et al. Pediatr Allergy Immunol. 2018 Dec.
No abstract available

Keywords: airway microbiota; children; infant; microbiome; respiratory infection; vitamin D.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest:The authors have no conflicts of interest relevant to this article to disclose.

Figures

Figure 1.
Figure 1.. Associations between nasopharyngeal microbiota profiles and risk of intensive care use in infants hospitalized for bronchiolitis by serum total 25-hydroxyvitamin D (25OHD) status
Random-effects model accounting for patient clustering at the hospital-level and adjusting for 12 factors (age, sex, race/ethnicity, gestational age, siblings at home, breastfeeding, history of breathing problems, lifetime history of systemic antibiotic use, weight at hospitalization, serum LL-37 level, and virology [RSV, rhinovirus]) was constructed for each strata – i.e., infants below or above the median serum total 25OHD levels (26.5 ng/ml). Moraxella-dominant profile was used as the reference. Full models are presented in Table E3.

References

    1. Hasegawa K, Mansbach JM, Ajami NJ, et al. Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis. Eur Respir J 2016;48:1329–1339. - PMC - PubMed
    1. Hasegawa K, Stewart CJ, Celedon JC, Mansbach JM, Tierney C, Camargo CA Jr. Circulating 25-hydroxyvitamin D, nasopharyngeal airway metabolome, and bronchiolitis severity. Allergy 2018;73:1135–1140. - PMC - PubMed
    1. Kanhere M, Chassaing B, Gewirtz AT, Tangpricha V. Role of vitamin D on gut microbiota in cystic fibrosis. J Steroid Biochem Mol Biol 2018;175:82–87. - PMC - PubMed
    1. Camargo CA Jr. Vitamin D, acute respiratory infection, and asthma/chronic obstructive pulmonary disease. In: Feldman D, Pike JW, Bouillon R, Giovannucci E, Goltzman D, Hewison M, eds. Vitamin D Fourth ed. Cambridge, MA: Elsevier Academic Press; 2018. pp. 1096–1120.
    1. Talsness CE, Penders J, Jansen E, Damoiseaux J, Thijs C, Mommers M. Influence of vitamin D on key bacterial taxa in infant microbiota in the KOALA Birth Cohort Study. PLoS One 2017;12:e0188011. - PMC - PubMed

Publication types